Follow CAP on Social Media

Listen to the CAP Podcast

Sinovac’s Limited Distribution in Africa May End Up Being a Blessing if Omicron Spreads

Source: Bridge Consulting

Distribution of Sinovac’s CoronaVac COVID-19 vaccine remains relatively limited in Africa, according to data from Bridge Consulting’s weekly vaccine tracker report. So, if the vaccine is not able to effectively counteract the Omicron variant, the overall impact will be limited.

Jabs made by Sinopharm account for the bulk of Chinese vaccine sales and donations in Africa and it is still not known how effectively their vaccine is able to protect against the new variant.

This marketing content will be shown in place of your protected content to anyone who is not allowed to read the post…

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.

China, Africa and the Global South... find out what’s happening.

Subscribe today for unlimited access.

What is The China-Africa Project?


The CAP is passionately independent, non-partisan and does not advocate for any country, company or culture.


A carefully curated selection of the day’s most important China-Africa stories. Updated 24 hours a day by human editors. No bots, no algorithms.


Diverse, often unconventional insights from scholars, analysts, journalist and a variety of stakeholders in the China-Africa discourse.


A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.